VIDEO: Medical home model could benefit inflammatory disease patients

ByRebecca L. Forand

CLEVELAND —In this video from the Medical Dermatology Therapy Update II meeting, Florian Rieder, MD, discusses how a medical home for inflammatory diseases could benefit patients.

Medical homes, in which a multidisciplinary team works together with patients, has worked well so far for gastroenterology patients and the model could be adapted for dermatologic and rheumatologic inflammatory diseases, according to Rieder, who is the guest chair of the gastroenterology and hepatology department at the Cleveland Clinic.

Published by:

Sources/Disclosures

Collapse

Source:

Florian Rieder, MD

Disclosures: Rieder reports financial relationships with 89Bio, Adnovate, AgomAb, Allergan, AbbVie, Arena, Boehringer-Ingelheim, Celgene/BMS, CDISC, Celsius, Cleveland Clinic Foundation, Cowen, Crohn’s and Colitis Foundation, ECCO, Ferring, Galapagos, Galmed, Genentech, German Research Foundation, Gilead, Gossamer, Guidepoint, Helmsley Charitable Trust, Horizon Therapeutics, Image Analysis Limited, Index Pharma, Janssen, Kenneth Rainin Foundation, Koutif, Mestag, Metacrine, Mopac, Morphic, National Institute of Health, Organovo, Origo, Pfizer, Pliant, Prometheus Biosciences, Receptos, RedX, Roche, Samsung, Surmodics, Surrozen, Takeda, Techlab, Theravance, Thetis, UCB and Ysios.

Read more

VIDEO: Medical home model could benefit inflammatory disease patients

Related Content